Physician

Bhavin Pravin Patel, M.D.

According to 2025 Medicare claims, Bhavin Patel, M.D. (NPI: 1750379913) practices allergy/immunology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is BHAVIN PATEL, M.D. P.C. (NPI: 1770645418) and primary practice location at 48307-2761.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 247 traditional Medicare patients, billed 22,184 HCPCS/CPT codes, and received $594,463 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,878 prescription claims across 312 beneficiaries totaling $418,704 in drug costs, led by Xolair (Omalizumab). DME data shows 119 claims. Open Payments data shows 56 records totaling $1,897. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $156,925 to $594,463. Similarly, Part D prescription costs have moved sharply higher in recent years, from $146,173 to $418,704. In contrast, DME billing represents a smaller volume and rose steadily, from $344 to $1,874.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	219	11,508	$156,925
2016	235	16,352	$274,212
2017	237	16,970	$328,881
2018	242	16,328	$319,654
2019	260	17,708	$386,125
2020	253	20,810	$531,665
2021	258	20,310	$558,507
2022	243	22,381	$637,987
2023	234	22,937	$652,272
2024	247	22,184	$594,463

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	227	1,383	$146,173
2016	236	1,674	$138,329
2017	237	1,621	$137,547
2018	261	1,727	$170,138
2019	277	1,592	$200,364
2020	262	1,452	$210,828
2021	275	1,545	$292,273
2022	274	1,540	$348,679
2023	283	1,650	$379,301
2024	312	1,878	$418,704

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	37	$338
2016	N/R	20	$117
2017	N/R	18	$63
2018	N/R	12	$34,636
2019	N/R	N/R	N/R
2020	N/R	80	$95,777
2021	N/R	98	$111,211
2022	N/R	95	$116,563
2023	N/R	104	$118,531
2024	N/R	119	$130,749

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	39	43	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	208	504	$60
94060	Test to measure expiratory airflow and volume changes before and after medication administration	110	227	$26
95165	Professional service for preparation and provision of 1 or more antigens	94	2,837	$10
95117	Professional service for multiple injections of allergen	103	1,512	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	26	728	$67,040
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	2,550	$52,205
Breo Ellipta	Fluticasone/Vilanterol	36	2,700	$33,988
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	38	1,620	$32,286
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	45	1,920	$10,375

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	27	$99,508
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	16	$23,626
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	18	$5,934
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	26	$951
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	32	$731

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	56	$1,897	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bhavin Pravin Patel, M.D.?

Tedicare shows public-source Medicare data for Bhavin Pravin Patel, M.D. (NPI 1750379913), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bhavin Pravin Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bhavin Pravin Patel, M.D.?

Bhavin Pravin Patel, M.D. is linked to BHAVIN PATEL, M.D. P.C. (billing NPI 1770645418) in the available physician profile data.

Does Bhavin Pravin Patel, M.D. have Open Payments data?

Bhavin Pravin Patel, M.D. has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.